Most material SEC filings — September 28, 2026

Milton C. Ault, III purchased 165,700 shares of Hyperscale Data Class A common stock between 09/15/2026 and 09/23/2026 at prices ranging from $0.1649 to $0.1859 per share, totaling approximately $28.5M. Simultaneously, Ault Company, Inc. purchased 850,000 shares between 09/16/2026 and 09/25/2026 at prices ranging from $0.1685 to $0.1852 per share, totaling approximately $147.5M. Combined, ~1.016M shares (~$176M) were acquired by Ault-controlled entities in a nine-day period.

On September 25, 2026, Jaguar Health agreed to exchange a partitioned portion of a secured promissory note originally issued to Streeterville Capital, LLC (a Utah LLC) on January 19, 2021, for an unspecified number of freely tradable common shares. The specific dollar amount of the partitioned note and share count are redacted in the filing (shown as blanks). The original note's remaining balance is reduced by the partitioned amount; no other consideration changes hands. The exchange is structured under Securities Act Section 3(a)(9) to permit unrestricted resale under Rule 144, with holding period tacking to January 19, 2021.

On September 25, 2026, a jury in Taction Technology v. Apple awarded $5.7 billion in damages. Burford Capital's financial entitlement is approximately $1.4 billion (split roughly equally between its balance sheet and investment funds), contingent on post-trial motions, appellate review, and collection. The filing emphasizes significant litigation and collection risks; verdicts of this magnitude rarely survive appellate process intact, and no cash has been received.

Moleculin announced publication of a peer-reviewed cardiac safety analysis in Frontiers in Cardiovascular Medicine examining 90 patients across five clinical trials of Annamycin (naxtarubicin). The pooled analysis, independently evaluated by Cleveland Clinic cardio-oncology, found no clinical or subclinical cardiotoxicity despite cumulative doses exceeding traditional anthracycline lifetime limits (median 660 mg/m²). Mean left ventricular ejection fraction remained stable at 60.6% baseline versus 60.0% post-treatment (p=0.84), with no dose-response relationship observed.

Brixmor Property Group (via EP/BRX Holdings LLC) entered into an arrangement agreement dated September 27, 2026 to acquire Slate Grocery REIT. The purchase price is $13.00 per unit plus daily Additional Consideration of $0.002482, payable in cash. The transaction is structured as a plan of arrangement under Ontario law and requires unitholder approval and court sanction. Closing targeted for on or after January 20, 2027, subject to customary closing conditions including financing (debt and equity commitments in place).